Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
29 May 2001 01:09 PM
RNS
Appointment
02 May 2001 05:56 PM
RNS
Additional Listing
24 Apr 2001 11:02 AM
RNS
Re Techmark Index
17 Apr 2001 04:20 PM
RNS
Completion of Fund Raising
17 Apr 2001 01:55 PM
RNS
Document regarding Listing Particulars
17 Apr 2001 07:00 AM
RNS
Results of EGM &Equity Issues
27 Mar 2001 07:00 AM
RNS
Successful patent application
12 Mar 2001 05:10 PM
RNS
Director Shareholding
12 Mar 2001 07:01 AM
RNS
Corporate Action
12 Mar 2001 07:01 AM
RNS
Full List/Placing& Open Offer
14 Feb 2001 03:59 PM
RNS
Additional Listing
13 Feb 2001 10:48 AM
RNS
Appointment
05 Feb 2001 07:00 AM
RNS
Acquisition of Technology
01 Feb 2001 04:35 PM
RNS
Access to Antibody Technology
26 Jan 2001 07:00 AM
RNS
Preliminary Results 2000
22 Jan 2001 07:00 AM
RNS
Agreement with AHP Signed
02 Jan 2001 05:13 PM
RNS
Board Appointment
02 Jan 2001 07:13 AM
RNS
TroVax into Clinical Trials
13 Dec 2000 07:00 AM
RNS
Collaboration with Valentis
04 Dec 2000 07:00 AM
RNS
New Technology Developed
06 Nov 2000 07:00 AM
RNS
First Clinical Trials
16 Oct 2000 07:00 AM
RNS
Ethical Approval for Trovax
28 Sep 2000 09:53 AM
RNS
Director Shareholding
26 Sep 2000 07:30 AM
RNS
Bioinformatics Collaboration
23 Aug 2000 11:51 AM
RNS
Employee Share Options
17 Aug 2000 04:17 PM
RNS
Additional Listing
16 Aug 2000 07:00 AM
RNS
Interim Results 2000
15 Aug 2000 05:48 PM
RNS
Additional Listing
15 Aug 2000 11:02 AM
RNS
Additional Listing
15 Aug 2000 07:00 AM
RNS
Research Update
10 Aug 2000 07:00 AM
RNS
Re Successful Fund Raising
08 Aug 2000 12:40 PM
RNS
Additional Listing
07 Aug 2000 01:25 PM
RNS
Statement re Press Comment
26 Jun 2000 08:21 AM
RNS
Research Update
06 Jun 2000 07:00 AM
RNS
Agreement
18 May 2000 11:05 AM
RNS
Agreements Signed, etc
02 May 2000 11:14 AM
RNS
Therapeutic Genes for Treatment of Cancer Acquired
31 Mar 2000 01:27 PM
RNS
Directors' Notification of Dealing in Shares
23 Mar 2000 04:29 PM
RNS
Directors' Dealings
21 Mar 2000 11:23 AM
RNS
Paul Durrands Appointed as Commercial Director
20 Mar 2000 12:08 PM
RNS
Agreement Signed with Nycomed Amersham Imaging
16 Mar 2000 08:39 AM
RNS
Human Genome/Patenting
08 Mar 2000 04:58 PM
RNS
Directors' Dealings
28 Feb 2000 08:19 AM
RNS
Gene Therapy Patent Obtained in the USA
24 Feb 2000 07:01 AM
RNS
Final Results - Year Ended 31 December 1999
21 Feb 2000 07:01 AM
RNS
Deal Signed on Novel Tumour Vaccine
14 Feb 2000 07:02 AM
RNS
Collaboration Agreement Signed with AstraZeneca
02 Feb 2000 07:01 AM
RNS
Successful Developments in Macrogen Cancer Therapy
24 Jan 2000 02:58 PM
RNS
Response to Press Comment on FDA Ruling
20 Jan 2000 04:13 PM
RNS
Holding in Company
UK 100

Latest directors dealings